2017 International Congress

June 4-8, 2017. Vancouver, BC.

View by Title View Sessions

View by Date

Tuesday, June 6, 2017

1:45pm-3:15pm: A Service Evaluation of the Clinical Use of Parkinson’s KinetiGraph (PKG) Movement Recording System in the Assessment of Parkinson’s Disease Patients with Tremor

J. Price, H. Martin, L. Ebenezer (Bronllys, United Kingdom)

Tremor · Exhibit Hall C

1:45pm-3:15pm: A survey-based analysis of abnormal movements in patients with Postural Tachycardia Syndrome (PoTS)

R. Pyda, A. Hohler (Boston, MA, USA)

Tremor · Exhibit Hall C

1:45pm-3:15pm: A Swedish family with Paroxysmal Kinesigenic Dyskinesia due to p.Arg217Profs*8 truncation in the proline-rich transmembrane protein 2 gene

P. Tsitsi, M. Paucar Arce, P. Svenningsson (Stockholm,, Sweden)

Genetics (Non-PD) · Exhibit Hall C

1:45pm-3:15pm: a-synuclein neurotoxicity and spreading using Lewy Body extracts from Parkinson Disease Brains: In vitro screening by cell-based assays

E. Bezard, F. Cavaliere, L. Cerf, B. Dehay, P. Ramos-Gonzalez, F. De Giorgi, M. Bourdenx, A. Bessede, J. Obeso, F. Ichas, C. Matute (Bordeaux, France)

Parkinson's Disease: Pathophysiology · Exhibit Hall C

1:45pm-3:15pm: AAV-mediated over-expression of VEGF-B in PINK1 gene knockout rats increases striatal dopamine content

T. Falk, M. Bartlett, D. Muller, B. Silashki, D. Farrell, K. Parent, M. Heien, S. Sherman (Tucson, AZ, USA)

Therapy in Movement Disorders · Exhibit Hall C

1:45pm-3:15pm: Abnormal activity in reward system in Parkinson’s disease patients with rapid eye movement sleep behavior disorder

C. BEAL, M.L. FANTINI, G. SESCOUSSE, M. ULLA, C. CHASSAIN, A. Marques, B. Pereira, N. VITELLO, P. BEUDIN, R. Colamarino, F. DURIF (Clermont-Ferrand, France)

Restless Legs Syndrome and Other Sleep Disorders · Exhibit Hall C

1:45pm-3:15pm: Addressing Involuntary Movements in Tardive Dyskinesia (AIM-TD): Efficacy, Safety, and Tolerability of Fixed-Dose Deutetrabenazine for the Treatment of Tardive Dyskinesia

K. Anderson, D. Stamler, M. Davis, S. Factor, R. Hauser, J. Isojärvi, J. Jimenez-Shahed, W. Ondo, H. Fernandez (Washington, DC, USA)

Drug-Induced Movement Disorders · Exhibit Hall C

1:45pm-3:15pm: Addressing Involuntary Movements in Tardive Dyskinesia (AIM-TD): Improvements in Clinical Global Impression of Change (CGIC) with Deutetrabenazine Treatment in Tardive Dyskinesia (TD)

J. Jimenez-Shahed, H. Fernandez, R. Hauser, M. Davis, S. Factor, J. Isojärvi, W. Ondo, D. Stamler, K. Anderson (Houston, TX, USA)

Drug-Induced Movement Disorders · Exhibit Hall C

1:45pm-3:15pm: Admission Diagnoses and Eventual Discharge Dispositions for Hospitalized Huntington’s Disease Patients: Results of a Nationwide Survey

S. Gupta, F. Benesh, V. Sung (Birmingham, AL, USA)

Huntington's Disease · Exhibit Hall C

1:45pm-3:15pm: Admixing augments nigral dopaminergic correlates during development to impart resistance to MPTP-toxicity at adulthood

V. D J, Y. H, R. T R, P. Anand Alladi (Bangalore, India)

Parkinson's Disease: Pathophysiology · Exhibit Hall C